Low-Dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: A randomized controlled trial

Jacob P. Lalezari, Jeffrey A. Beal, Peter J. Ruane, Calvin J. Cohen, Elizabeth L. Jacobson, David Sundin, D. Pharm, F. Wai Ping Leong, Stephen P. Raffanti, David A. Wheeler, Roger D. Anderson, Philip Keiser, Shannon R. Schrader, C. Jeffrey Goodgame, Corklin R. Steinhart, Robert L. Murphy, Maurice J. Wolin, Kendall A. Smith

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Low-Dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: A randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences